Venture
Veradermics, Inc
Latest Form D 2026-05-15- CIK 1827635
- State CT
- Other Health Care
- 6 Form D offerings since 2020-10-09
- Total sold
- $269M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2020-10-09
- Latest round
- $30M
- 2026-05-15 · 021-584260
- Investors
- 2
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-05-15 · $30M
- 2020-10-09$476K021-377538
- 2021-10-06$22.2M021-415905
- 2023-05-01$15M021-480424
- 2024-12-10$66.6M021-531652
- 2025-10-28$135M021-562294
- 2026-05-15$30M021-584260
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($135M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-584260 | First filed2026-05-15 | Latest2026-05-15 | Sought$30M | Sold$30M | Investors2 | Exemptions506(b) |
| 021-562294 | First filed2025-10-28 | Latest2025-10-28 | Sought$150M | Sold$135M | Investors40 | Exemptions506(b) |
| 021-531652 | First filed2024-12-10 | Latest2024-12-10 | Sought$75M | Sold$66.6M | Investors40 | Exemptions506(b) |
| 021-480424 | First filed2023-05-01 | Latest2023-05-01 | Sought$15M | Sold$15M | Investors16 | Exemptions506(b) |
| 021-415905 | First filed2021-10-06 | Latest2021-10-07 | Sought$22.2M | Sold$22.2M | Investors41 | Exemptions506(b) |
| 021-377538 | First filed2020-10-09 | Latest2020-10-09 | Sought$1.5M | Sold$476K | Investors1 | Exemptions506(b) |
Who backs Veradermics, Inc, inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-05-15
| Name | Relationship |
|---|---|
| REID WALDMAN | RelationshipExecutive Officer, Director |
| TIM DURSO | RelationshipExecutive Officer |
| DOMINIC CARRANO | RelationshipExecutive Officer |
| MICHAEL GRECO | RelationshipExecutive Officer |
| MARK NEUMANN | RelationshipExecutive Officer |
| VLADIMIR CORIC | RelationshipDirector |
| JOHN CHILDS | RelationshipDirector |
| PATRICK ENRIGHT | RelationshipDirector |
| JANE GRANT-KELS | RelationshipDirector |
| KATARINA PANCE | RelationshipDirector |
| DAVID FRIEDMAN | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| CANTOR FITZGERALD & CO. | CRD134 | Broker-dealer— | Offerings1 |
| CITIGROUP GLOBAL MARKETS INC. | CRD7059 | Broker-dealer— | Offerings1 |
| JEFFERIES LLC | CRD2347 | Broker-dealer— | Offerings1 |
| LEERINK PARTNERS LLC | CRD39011 | Broker-dealer— | Offerings1 |
| LIFESCI CAPITAL | CRD168404 | Broker-dealer— | Offerings1 |
| NEEDHAM & COMPANY, LLC | CRD16360 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Connecticut (CT)
- Exemptions
- Rule 506(b)
- First filed
- 2020-10-09
- Latest filing
- 2026-05-15
Who backs Veradermics, Inc
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗